Morgan Stanley Procept Bio Robotics Corp Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRCT
# of Institutions
271Shares Held
38.7MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$238 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$105 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$85.1 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$80.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.05B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...